1. ADAM10 and ADAM17 cleave PD-L1 to mediate PD-(L)1 inhibitor resistance. (1st January 2020) Authors: Orme, Jacob J.; Jazieh, Khalid A.; Xie, Tiancheng; Harrington, Susan; Liu, Xin; Ball, Matthew; Madden, Benjamin; Charlesworth, M. Cristine; Azam, Tariq U.; Lucien, Fabrice; Wootla, Bharath; Li, Yanli; Villasboas, Jose Caetano; Mansfield, Aaron S.; Dronca, Roxana S.; Dong, Haidong Journal: Oncoimmunology Issue: Volume 9:Number 1(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. BCL-2-interacting mediator of cell death (Bim) is a novel biomarker for response to anti-PD-1 therapy in patients with advanced melanoma. (December 2016) Authors: Dronca, Roxana S; Mansfield, Aaron S; Park, Sean S; Dong, Haidong Journal: Immunotherapy Issue: Volume 8:Number 12(2016:Dec.) Page Start: 1351 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Bim and PD-1 identify effector CD8 T cells responsive to anti-PD-1 therapy in metastatic melanoma patients. (4th November 2015) Authors: Dronca, Roxana; Liu, Xin; Lisa, Kottschade; Mcwilliams, Rob; Markovic, Svetomir; Dong, Haidong Journal: Journal for immunotherapy of cancer Issue: Volume 3(2015)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Bim and PD-1 identify effector CD8 T cells responsive to anti-PD-1 therapy in metastatic melanoma patients. Issue 2 (December 2015) Authors: Dronca, Roxana; Liu, Xin; Lisa, Kottschade; Mcwilliams, Rob; Markovic, Svetomir; Dong, Haidong Journal: Journal for immunotherapy of cancer Issue: Volume 3:Issue 2(2015) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Chemo-immunotherapy combination after PD-1 inhibitor failure improves clinical outcomes in metastatic melanoma patients. Issue 4 (August 2020) Authors: Vera Aguilera, Jesus; Paludo, Jonas; McWilliams, Robert R.; Zhang, Henan; Li, Ying; Kumar, Anagha B.; Failing, Jarrett; Kottschade, Lisa A.; Block, Matthew S.; Markovic, Svetomir N.; Dong, Haidong; Dronca, Roxana S.; Yan, Yiyi Journal: Melanoma research Issue: Volume 30:Issue 4(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Concordance of PD‐1 and PD‐L1 (B7‐H1) in paired primary and metastatic clear cell renal cell carcinoma. (12th December 2019) Authors: Eckel‐Passow, Jeanette E.; Ho, Thai H.; Serie, Daniel J.; Cheville, John C.; Houston Thompson, R.; Costello, Brian A.; Dong, Haidong; Kwon, Eugene D.; Leibovich, Bradley C.; Parker, Alexander S. Journal: Cancer medicine Issue: Volume 9:Number 3(2020) Page Start: 1152 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Corrigendum to "Targeting B7-H1 (PD-L1) sensitizes cancer cells to chemotherapy" [Heliyon 4 (12) (December 2018) e01039]. Issue 3 (March 2019) Authors: Wu, Xiaosheng; Li, Yanli; Liu, Xin; Chen, Chunhua; Harrington, Susan M.; Cao, Siyu; Xie, Tiancheng; Pham, Tu; Mansfield, Aaron S.; Yan, Yiyi; Kwon, Eugene D.; Wang, Liewei; Ling, Kun; Dong, Haidong Journal: Heliyon Issue: Volume 5:Issue 3(2019) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. First Report of Dramatic Tumor Responses with Ramucirumab and Paclitaxel After Progression on Pembrolizumab in Two Cases of Metastatic Gastroesophageal Adenocarcinoma. (19th April 2018) Authors: Chakrabarti, Sakti; Dong, Haidong; Paripati, Harshita R.; Ross, Helen J.; Yoon, Harry H. Journal: Oncologist Issue: Volume 23:Number 7(2018) Page Start: 840 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. IMMU-36. THE ROLE OF PD-L1 IN GLIOBLASTOMA-DERIVED EXTRACELLULAR VESICLES IN THE INDUCTION OF IMMUNOSUPPRESSIVE MONOCYTES. (11th November 2019) Authors: Himes, Benjamin; Peterson, Timothy; Tyson, Jasmine; Lee, Helen; deMooij, Tristan; Cumba-Garcia, Luz; Jung, Mi-Yeon; Gustafson, Michael; Dietz, Allan; Johnson, Aaron; Dong, Haidong; Maus, Rachel; Svetomir, Markovic; Lucien-Matteoni, Fabrice; Yan, David; Uhm, Sarah; Abukhadra, Mina; Parney, Daniel;... Journal: Neuro-oncology Issue: Volume 21(2019)Supplement 6 Page Start: vi126 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Immune checkpoint molecules soluble program death ligand 1 and galectin‐9 are increased in pregnancy. (4th December 2017) Authors: Enninga, Elizabeth Ann L.; Harrington, Susan M.; Creedon, Douglas J.; Ruano, Rodrigo; Markovic, Svetomir N.; Dong, Haidong; Dronca, Roxana S. Journal: American journal of reproductive immunology Issue: Volume 79:Number 2(2018) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗